General Information of Drug (ID: DMCK8SX)

Drug Name
MDX-1097 Drug Info
Synonyms CKap; MKap; K-1-21; Mab therapy, Immune System therapeutics/Medarex; Monoclonal antibody (multiple myeloma, humanized/murine/chimeric), PacMab/Medarex
Indication
Disease Entry ICD 11 Status REF
Haematological malignancy 2B33.Y Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMCK8SX

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Kappa myeloma antigen (KMA) TT1HM0R NOUNIPROTAC Not Available [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025289)
2 MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide. Br J Haematol. 2015 May;169(3):333-43.